News and Trends 21 Jun 2022 New data demonstrates clinical potential of Inivata’s RaDaR technology for breast cancer Data supporting the detection of minimal residual disease (MRD) has highlighted potential to provide an early predictor of tumor recurrence in patients who have had breast cancer. Liquid biopsy company Inivata announced the new data in support of its new RaDaR assay for the detection of MRD in those with high-risk hormone receptor-positive (HR+), human […] June 21, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 21 Jun 2022 Treatment for highly-sensitized kidney transplant patients approved and recommended Treatment offered by Hansa Biopharma for the densensitization of highly sensitized adults prior to kidney transplants from deceased donors has been recommended by the UK’s National Institute for Health and Care Excellence (NICE). NICE considers Idefirix (imlifidase), made by Hansa, a Swedish company that specializes in enzyme technology for rare immunological conditions, to be a […] June 21, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 21 Jun 2022 Therorna funding to accelerate circRNA-based platform Therorna Inc., a Chinese biotech company specializing in the development of circular RNA (circRNA) technology-based new vaccines and therapies, including for COVID-19, has completed a $42 million series A financing round. The funding was co-led by MSA Capital, with participation from Sherpa Healthcare Partners, 3H Health Investment, and existing investors Quan Capital and Cenova Capital. […] June 21, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 21 Jun 2022 Elypta raises $21M to develop early detection test for all cancers Elypta, a Swedish diagnostics company aiming to commercialize the first metabolism-based liquid biopsy for early detection of any cancer, has raised $21 million in a series A financing round led by Bonnier Ventures. “The series A is a pivotal moment for Elypta as it fully funds the development of our two leading indications,” said Karl […] June 21, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 21 Jun 2022 Immuneel Therapeutics raises $15M and starts patient trials for CAR-T cancer therapies Indian biotech start-up Immuneel Therapeutics has announced it has started patient dosing in a CAR-T trial named “IMAGINE.” The Indian company focuses on creating access to Chimeric Antigen Receptor T cell therapy (CAR-T) and other cellular immunotherapies for the management and treatment of cancers. The phase II trial is the first industry sponsored CAR-T trial […] June 21, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 21 Jun 2022 Biotalys and Novozymes partner on biofungicide Belgian agtech company Biotalys and Danish biotech company Novozymes have entered into a partnership to expand opportunities for Evoca, Biotalys’ first proprietary biocontrol product. Novozymes will explore additional routes for the upscaling and production of the bioactive protein of Evoca, with the option of a possible commercial collaboration for a future generation of the product. […] June 21, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 21 Jun 2022 Elektrofi raises $40M to develop drug formulation and delivery pipeline Boston, U.S.-based biotech Elektrofi has completed a $40 million series B funding round. The company, which focuses on drug formulation and delivery, will use a portion of the proceeds to establish a centralized manufacturing line to support multiple upcoming clinical trials. The company also aims to double staff numbers over the next 12-18 months to […] June 21, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 21 Jun 2022 New agreement could lead to first African-owned COVID-19 vaccine A year after the creation of the mRNA Vaccine Technology Transfer Hub, two biotech companies – Afrigen Biologics and the Univercells Group – are set to work together. The agreement intends to pave the way for the development of the first African-owned COVID-19 vaccine. The collaboration will focus on the development of a novel mRNA […] June 21, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 21 Jun 2022 Aussie uni develops new 3D printing solution for stem cell manufacturing Researchers at the University of Technology Sydney (UTS), Australia, have developed a 3D printed system for harvesting stem cells from bioreactors. The scientists said this could lead to high quality, wide-scale production of stem cells in Australia at a lower cost. Stem cells offer great promise in the treatment of many diseases and injuries, from […] June 21, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Inside Labiotech 21 Jun 2022 How you can get involved in helping the industry–academia community solve global challenges IN-PART’s ‘Global Challenge’ campaigns were born out of the response to COVID-19 in March 2020. As the impacts of the pandemic began to take hold, IN-PART recognized its position at the interface of industry and academia and its responsibility to leverage its networks to generate solutions to the unfolding crisis. Through online matchmaking platforms, IN-PART […] June 21, 2022 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 20 Jun 2022 Investment in Hyperthermics’ process to turn biowaste into energy and proteins Farvatn Private Equity and Måsøval Eiendom have invested in the Norwegian biotechnology company Hyperthermics AS. Through the investment, Farvatn and Måsøval now hold approximately 11% of the shares in Hyperthermics. Hyperthermics’ technology is based on hyperthermophilic bacteria, which degrade biomass, resulting in biogas and protein production. The high temperatures involved – 80ºC – speed up […] June 20, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 20 Jun 2022 Boost for dementia gene-based therapies The Cell and Gene Therapy Catapult (CGT Catapult) and the UK Dementia Research Institute (UK DRI) have announced a collaboration to accelerate the clinical development of adeno-associated virus (AAV) based gene therapies for dementia. Since 2015, dementia has been one of the leading causes of mortality in the UK. While new and improved treatments for […] June 20, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email